ReachMD

Episodes 1-15 of 18

• • 

    

    Scott Kopetz, MD, PhD

    Peer

  • 

    

    Elena Elez, MD, PhD

    Peer

  • 

    

    Elizabeth Smyth, MD

    Peer

  0

  

  RestartResume

  Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer

  Clarifying the Value of Anti-EGFR Therapy in Metastatic Colorectal Cancer

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  4

  

  RestartResume

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  Keeping Pace in Lung Cancer: Guidelines and the Future Direction of Immunotherapy in NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Vivek Subbiah, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Improving Outcomes for Patients with RET-Positive NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  1

  

  RestartResume

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  Keeping Pace in Lung Cancer: Clinical Case Challenges in NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Sandip Patel, MD

    Peer

  2

  

  RestartResume

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  Keeping Pace in Lung Cancer: Integration of Immune Checkpoint Inhibitors as Initial Therapy for Advanced Disease

  0.25 credits

• • 

    

    Joël Guigay, MD, PhD

    Peer

  • 

    

    Kevin J. Harrington, MD

    Peer

  2

  

  RestartResume

  Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities

  Unravel Global Clinical Complexities in Head and Neck Cancers: Identifying Approaches to Improve Outcomes with Manageable Toxicities

  0.25 credits

• • 

    

    Daniel P. Petrylak, MD

    Peer

  • 

    

    Arlene O. Siefker-Radtke, MD

    Peer

  5

  

  RestartResume

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  Keeping Pace in Bladder Cancers: All About Sequencing in Locally Advanced or Metastatic Urothelial Carcinoma

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Justin Gainor, MD

    Peer

  3

  

  RestartResume

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  Keeping Pace in Lung Cancer: Applying the Right Therapy to the Right Patient in RET-Positive NSCLC

  0.25 credits

• • 

    

    Lauren Ritterhouse, MD ,PhD

    Peer

  • 

    

    Pasi Antero Jänne, MD, PhD

    Peer

  • 

    

    Kanwal Raghav, MD

    Peer

  2

  

  RestartResume

  The Role of HER3 Expression in Advanced Solid Tumors

  The Role of HER3 Expression in Advanced Solid Tumors

  0.50 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    Edward B. Garon, MD, MS

    Peer

  3

  

  RestartResume

  Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC

  Keeping Pace in Lung Cancer – All About Antiangiogenics and TKIs: Current Roles and Future Directions in EGFR-Mutant NSCLC

  0.25 credits

• • 

    

    Mark Socinski, MD

    Peer

  • 

    

    John V. Heymach, MD, PhD

    Peer

  3

  

  RestartResume

  Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC

  Keeping Pace in Lung Cancer – How Would You Treat? Case-Based Learning in EGFR-Mutant NSCLC

  0.25 credits

• • 

    

    Jay Raman, MD, FACS

    Peer

  • 

    

    Oguz Akin, MD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  • 

    

    Elizabeth Plimack, MD, MS

    Peer

  0

  

  RestartResume

  RCC Treatment Strategies in a Favorable-Risk Patient

  RCC Treatment Strategies in a Favorable-Risk Patient

  0.50 credits

• • 

    

    Jay Raman, MD, FACS

    Peer

  • 

    

    Oguz Akin, MD

    Peer

  • 

    

    Robert J. Motzer, MD

    Peer

  • 

    

    Elizabeth Plimack, MD, MS

    Peer

  2

  

  RestartResume

  RCC Treatment Strategies in a Poor-Risk Patient

  RCC Treatment Strategies in a Poor-Risk Patient

  0.50 credits

• • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  • 

    

    Nina Delaney Wagner-Johnston, MD

    Peer

  • 

    

    Seema A. Bhat, MD

    Peer

  2

  

  RestartResume

  The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

  The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

  0.50 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Anna-Barbara Moscicki, MD

    Peer

  26

  

  RestartResume

  Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping

  Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping

  0.25 credits

• 1
• 2
• Next